Dover (DOV) Is At $101.12 Formed Wedge; Shorts at Protagonist Therapeutics (PTGX) Lowered By 7.56%

Protagonist Therapeutics Incorporated (NASDAQ:PTGX) had a decrease of 7.56% in short interest. PTGX’s SI was 358,500 shares in December as released by FINRA. Its down 7.56% from 387,800 shares previously. With 89,200 avg volume, 4 days are for Protagonist Therapeutics Incorporated (NASDAQ:PTGX)’s short sellers to cover PTGX’s short positions. The SI to Protagonist Therapeutics Incorporated’s float is 5.06%. The stock increased 4.15% or $0.81 during the last trading session, reaching $20.31. About 139,212 shares traded or 10.72% up from the average. Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has 0.00% since December 27, 2016 and is . It has underperformed by 16.70% the S&P500.

Dover Corporation (DOV) formed wedge up with $108.20 target or 7.00% above today’s $101.12 share price. Dover Corporation (DOV) has $15.75B valuation. The stock increased 0.66% or $0.66 during the last trading session, reaching $101.12. About 546,257 shares traded. Dover Corporation (NYSE:DOV) has risen 29.68% since December 27, 2016 and is uptrending. It has outperformed by 12.98% the S&P500.

Among 23 analysts covering Dover (NYSE:DOV), 13 have Buy rating, 0 Sell and 10 Hold. Therefore 57% are positive. Dover has $107.0 highest and $51 lowest target. $85’s average target is -15.94% below currents $101.12 stock price. Dover had 81 analyst reports since July 22, 2015 according to SRatingsIntel. As per Friday, August 25, the company rating was maintained by BMO Capital Markets. As per Monday, October 5, the company rating was maintained by Barclays Capital. The firm has “Sell” rating given on Wednesday, January 13 by UBS. The firm has “Buy” rating by Vertical Research given on Tuesday, January 3. The company was upgraded on Wednesday, September 20 by J.P. Morgan. The stock of Dover Corporation (NYSE:DOV) earned “Hold” rating by Oppenheimer on Wednesday, June 7. As per Tuesday, November 3, the company rating was initiated by SunTrust. BMO Capital Markets maintained Dover Corporation (NYSE:DOV) rating on Thursday, July 20. BMO Capital Markets has “Buy” rating and $9400 target. Credit Suisse maintained Dover Corporation (NYSE:DOV) rating on Monday, March 14. Credit Suisse has “Outperform” rating and $73 target. As per Tuesday, September 19, the company rating was maintained by Morgan Stanley.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.13, from 0.91 in 2017Q2. It increased, as 33 investors sold Dover Corporation shares while 190 reduced holdings. 76 funds opened positions while 157 raised stakes. 130.20 million shares or 1.96% less from 132.81 million shares in 2017Q2 were reported. Moreover, Voloridge Inv Ltd Liability has 0.01% invested in Dover Corporation (NYSE:DOV). Inverness Counsel Limited Liability reported 858,225 shares stake. Natl Planning holds 2,931 shares. Srb Corporation owns 2,077 shares. Stevens Cap Mngmt Lp holds 0.1% in Dover Corporation (NYSE:DOV) or 30,437 shares. Nomura Holdg invested 0.01% of its portfolio in Dover Corporation (NYSE:DOV). United Services Automobile Association, Texas-based fund reported 137,881 shares. Cincinnati Indemnity Com holds 29,000 shares. Hancock Co stated it has 0.08% in Dover Corporation (NYSE:DOV). Federated Incorporated Pa holds 0% in Dover Corporation (NYSE:DOV) or 3,204 shares. Horan Capital Limited Liability Corporation holds 500 shares. Farmers Bancorp reported 0.16% stake. Credit Agricole S A reported 158,620 shares. Ubs Asset Americas holds 0.04% of its portfolio in Dover Corporation (NYSE:DOV) for 517,734 shares. Robeco Institutional Asset Bv has 0% invested in Dover Corporation (NYSE:DOV) for 7,545 shares.

Analysts await Dover Corporation (NYSE:DOV) to report earnings on January, 25. They expect $1.04 EPS, up 46.48% or $0.33 from last year’s $0.71 per share. DOV’s profit will be $162.03 million for 24.31 P/E if the $1.04 EPS becomes a reality. After $1.16 actual EPS reported by Dover Corporation for the previous quarter, Wall Street now forecasts -10.34% negative EPS growth.

Since August 4, 2017, it had 0 insider purchases, and 5 selling transactions for $8.01 million activity. The insider STUBBS MICHAEL B sold 25,000 shares worth $2.18M. Shares for $419,100 were sold by Goldberg Paul. Spurgeon William also sold $624,203 worth of Dover Corporation (NYSE:DOV) on Thursday, October 26.